(3R, 5R)-Rosuvastatin Size:Contact [email protected] for quotation coronary artery disease

coronary artery disease

The intensity of R123 fluorescence has a peak at concentration of 50 μM

A 6-month treatment (from the 18th to the 24th month of life) with an oral daily dose of 10 mg/kg of darodipine restores in part the expression of 200 kDa-NF subunit immunoreactivity in the cerebellar cortex

CC[C@H](C)C(=O)O[C@H]1CC=CC2=C[C@@H](O)[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC([O-])=O)[C@H]21

InChiKey: KTUFNOKKBVMGRW-AZGHYOHESA-N

(3R, 5R)-Rosuvastatin Size:Contact [email protected] for quotation coronary artery disease(3R,5R) Rosuvastatin is the (3R,5R) enantiomer of Rosuvastatin. Rosuvastatin is a competitive HMG CoA reductase inhibitor with an IC50 of 11 nM. Rosuvastatin potently blocks human ether a go go related gene (hERG) current with an IC50 of 195 nM. Rosuvastatin reduces the expression of the mature hERG and the interaction of heat shock protein 70 (Hsp70) with the hERG protein. Rosuvastatin is very effective in lowering low density lipoprotein (LDL)